Thus, 25.8% patients exhibiting genotypes TNFα308GA – LTα + 252AG and 31% patients having TNFα308GG – LTα + 252AA demonstrated ultrasound signs of cirrhosis development whereas the frequencies of portal hypertension in these two groups were 6.2% and 13.8%, respectively. This evidence concerns the gene LTA and Cirrhosis.